Literature DB >> 17709328

Body mass index and risk of Parkinson's disease: a prospective cohort study.

Giancarlo Logroscino1, Howard D Sesso, Ralph S Paffenbarger, I-Min Lee.   

Abstract

High body mass index has been associated with increased risk of several chronic diseases, including cardiovascular disease, and, recently, Alzheimer's disease. There are few data on the association of body mass index with Parkinson's disease, and results have been inconsistent. The authors conducted a prospective study among 10,812 men in the Harvard Alumni Health Study, followed from 1988 to 1998 (mean age at baseline: 67.7 years), to test the hypothesis that body mass index is associated with Parkinson's disease risk. Among 106 incident cases of Parkinson's disease, body mass index at baseline was not associated with Parkinson's disease risk (for body mass index <22.5, 22.5-<24.9, and > or =25.0 kg/m2: multivariate relative risks = 1.51 (95% confidence interval: 0.95, 2.40), 1.00 (referent), and 0.86 (95% confidence interval: 0.53, 1.41)). The authors had information on body mass index during late adolescence, when men entered college; this was unrelated to Parkinson's disease risk as well. Subjects who lost at least 0.5 units of body mass index per decade between college entry and 1988 had a significantly increased Parkinson's disease risk, compared with men having stable body mass index (multivariate relative risk = 2.60, 95% confidence interval: 1.10, 6.10). The authors conclude that body mass index is unrelated to Parkinson's disease risk and speculate that the observation of increased risk with body mass index loss since late adolescence may reflect weight loss due to Parkinson's disease that preceded clinical diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17709328     DOI: 10.1093/aje/kwm211

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  20 in total

1.  Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.

Authors:  Anne-Marie A Wills; Adriana Pérez; Jue Wang; Xiao Su; John Morgan; Suja S Rajan; Maureen A Leehey; Gregory M Pontone; Kelvin L Chou; Chizoba Umeh; Zoltan Mari; James Boyd
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

2.  Reduced risk of Parkinson's disease associated with lower body mass index and heavy leisure-time physical activity.

Authors:  Katri Sääksjärvi; Paul Knekt; Satu Männistö; Jukka Lyytinen; Tuija Jääskeläinen; Noora Kanerva; Markku Heliövaara
Journal:  Eur J Epidemiol       Date:  2014-03-16       Impact factor: 8.082

Review 3.  Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.

Authors:  Huan Cai; Wei-na Cong; Sunggoan Ji; Sarah Rothman; Stuart Maudsley; Bronwen Martin
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

4.  Waist circumference and risk of Parkinson's disease.

Authors:  Kye-Yeung Park; Ga Eun Nam; Kyungdo Han; Hoon-Ki Park; Hwan-Sik Hwang
Journal:  NPJ Parkinsons Dis       Date:  2022-07-08

5.  Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Honglei Chen; Thomas H Mosley; Alvaro Alonso; Xuemei Huang
Journal:  Am J Epidemiol       Date:  2009-03-18       Impact factor: 4.897

Review 6.  Obesity in elderly subjects: in sheep's clothing perhaps, but still a wolf!

Authors:  Etty Osher; Naftali Stern
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

7.  Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.

Authors:  K Marder; H Zhao; S Eberly; C M Tanner; D Oakes; I Shoulson
Journal:  Neurology       Date:  2009-08-04       Impact factor: 9.910

8.  Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection.

Authors:  Jacqueline A Bayliss; Zane B Andrews
Journal:  Ther Adv Endocrinol Metab       Date:  2013-02       Impact factor: 3.565

9.  Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007.

Authors:  Jeff Bronstein; Paul Carvey; Honglei Chen; Deborah Cory-Slechta; Donato DiMonte; John Duda; Paul English; Samuel Goldman; Stephen Grate; Johnni Hansen; Jane Hoppin; Sarah Jewell; Freya Kamel; Walter Koroshetz; James W Langston; Giancarlo Logroscino; Lorene Nelson; Bernard Ravina; Walter Rocca; George W Ross; Ted Schettler; Michael Schwarzschild; Bill Scott; Richard Seegal; Andrew Singleton; Kyle Steenland; Caroline M Tanner; Stephen Van Den Eeden; Marc Weisskopf
Journal:  Environ Health Perspect       Date:  2008-08-26       Impact factor: 9.031

10.  Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.

Authors:  Maureen Leehey; Sheng Luo; Saloni Sharma; Anne-Marie A Wills; Jacquelyn L Bainbridge; Pei Shieen Wong; David K Simon; Jay Schneider; Yunxi Zhang; Adriana Pérez; Rohit Dhall; Chadwick W Christine; Carlos Singer; Franca Cambi; James T Boyd
Journal:  Neurology       Date:  2017-09-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.